SCHEDULE 13G

Beta Bionics Inc

Common Stock · CUSIP: 08659B102

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Soleus BB SPV, LLC

  Shares: 595,176.00 · Class: 1.4%

• Soleus Private Equity Fund I, L.P.

  Shares: 396,204.00 · Class: 0.9%

• Soleus Private Equity GP I, LLC

  Shares: 991,380.00 · Class: 2.3%

• Soleus PE GP I, LLC

  Shares: 991,380.00 · Class: 2.3%

• Soleus Private Equity Fund II, L.P.

  Shares: 1,703,961.00 · Class: 3.9%

• Soleus Private Equity GP II, LLC

  Shares: 1,703,961.00 · Class: 3.9%

• Soleus PE GP II, LLC

  Shares: 1,703,961.00 · Class: 3.9%

• Soleus Capital Master Fund, L.P.

  Shares: 1,100,000.00 · Class: 2.5%

• Soleus Capital, LLC

  Shares: 1,100,000.00 · Class: 2.5%

• Soleus Capital Group, LLC

  Shares: 1,100,000.00 · Class: 2.5%

• Soleus Capital Management, L.P.

  Shares: 3,795,341.00 · Class: 8.8%

• Soleus GP, LLC

  Shares: 3,795,341.00 · Class: 8.8%

• Guy Levy

  Shares: 3,795,341.00 · Class: 8.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.